News & analysis on the clinical development and manufacture of large molecule drugs
Hired and Retired: Spring cleaning
By Ben Hargreaves
- Last updated on
As we enter spring, several companies have refreshed the look of their executive boards – some to strengthen their direction and some out of necessity.
Leadership of a company can be a powerful signal of intent for companies, as two people found out this month – with one exiting, after manufacturing woes resulted in US Food and Drug Administration action, and one joining to lead a newly spunout, oncology-focused biotech from one of the largest companies in the industry.